Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
7 Görünümler
• 07/30/23
0
0
gömmek
administrator
Aboneler
Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar